Aegera

Aegera Therapeutics was a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs in oncology and neuropathic pain. Aegera was acquired by PharmaScience in 2011.

Location

Verdun, Canada

History

Acquired by Pharmascience in 2011

Related companies

Leave a Comment

Your email address will not be published. Required fields are marked *